A warning has been issued to Gedling borough residents after it was revealed reports had been received of unlicensed anti-wrinkle injections being administered in the area that could cause ”permanent facial disfigurement’.
Gedling Borough Council’s Public Protection Team has issued the warning about anti-wrinkle treatments containing botulinum toxin are prescription-only medicines regulated by the Medicines and Healthcare Regulatory Agency (MHRA).
The use of unlicensed products is illegal and poses significant risks, including potential facial scarring and permanent disfigurement.
Currently, only six brands of botulinum toxin are licensed for cosmetic use in the UK and these are Azzalure®, Bocouture®, Botox®, Alluzience®, Letybo®, and Nuceiva®.
Councillor David Ellis, Portfolio Holder for Public Protection at Gedling Borough Council, said: “We have received reports of potentially dangerous, unlicensed products being offered in treatments in Gedling Borough. These products are illegal and may be carried out by individuals who are putting people at serious risk for financial gain.”
Residents with concerns or information are encouraged to contact Gedling Borough Council’s Public Protection Team at enquiries@gedling.gov.uk. Practitioners seeking additional guidance can also reach out for support.
The government has previously announced plans to introduce a licensing regime for non-surgical cosmetic procedures, such as Botox, fillers, and other treatments, to address concerns about unregulated practices. This proposed system aims to standardise qualifications, hygiene, and safety requirements. Gedling Borough Council said they are awaiting further updates on the implementation of these measures.
Residents considering such treatments should be aware of the following safety guidelines:
- Verify the product: Ensure the name of the product is listed among the licensed brands. Products such as Botulax, reNTox, and Innotox are not authorised for use in the UK.
- Check the practitioner’s credentials: Confirm their qualifications, training in aesthetics, and experience with injectable treatments.
- Ask about insurance: Ensure the practitioner has appropriate insurance cover.
- Inspect the product: Confirm the product vial is sealed before use and that it is prescribed specifically for the individual undergoing treatment.
A face-to-face consultation with a qualified prescriber is essential before any treatment. This consultation should include a thorough review of the individual’s medical history and an assessment of their suitability for the procedure.
For more details, refer to the Joint Council for Cosmetic Practitioners’ information sheets on cosmetic treatments including Botulinum Toxins – treatments
